Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer.

Targeting MET and vascular endothelial growth factor receptor signaling in castration-resistant prostate cancer. Cancer J. 2013 Jan-Feb; 19(1):90-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.